This information was published on 2025-07-28T08:40:58 for IP Right Registration Published.
| Field | Value |
| (210) | 2545920 (IR 1853792) |
| (220) |
02 Apr 2025
|
| (300) |
US, 10 Oct 2024, 98794435
|
| (511) (510) |
Class 5
Small molecule pharmaceutical preparations for use in cell and gene therapy for treating respiratory and infectious diseases and metabolic disorders, and diseases and disorders of the neurological, oncology, cardiovascular, immune, endocrine, gastrointestinal, ophthalmic, dermatologic and hematologic systems. |
| (540) | RDRUG |
| (550) | Word |
| (730) |
Rgenta Therapeutics, Inc.
|
Find out more about publications on the About page.